Nicole Oliver, MD
Obstetrics & Gynecology · Hendersonville, TNNPI 1952533663
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 24.3% of the total.
Across 106 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$518
- Astellas Pharma US Inc$244
- Organon$227
- Coopersurgical, Inc.$123
- Bayer$112
- Mayne Pharma Commercial LLC$95
- plus $815 from 24 others
What the payments were for
- Food & beverage$2,135100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $518 |
| Astellas Pharma US Inc | 13 | $244 |
| Organon | 10 | $227 |
| Coopersurgical, Inc. | 7 | $123 |
| Bayer | 5 | $112 |
| Mayne Pharma Commercial LLC | 5 | $95 |
| Pfizer | 4 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $70 |
| Aspira Women's Health Inc | 2 | $64 |
| Bard Access Systems, Inc. | 1 | $57 |
| Biogen | 3 | $50 |
| Shield Therapeutics Inc | 2 | $48 |
| Hologic Sales And Service, LLC | 2 | $46 |
| Vertex | 2 | $43 |
| Exact Sciences | 2 | $40 |
| Covidien LP | 1 | $33 |
| Therapeuticsmd, Inc. | 2 | $33 |
| Medtronic | 2 | $28 |
| Agile Therapeutics, Inc. | 2 | $27 |
| Olympus America Inc. | 1 | $25 |
| Amgen | 1 | $24 |
| Myovant Sciences Inc. | 1 | $23 |
| Bard Peripheral Vascular, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $17 |
| Millicent US Inc | 1 | $16 |
| Avion Pharmaceuticals | 1 | $16 |
| Merck | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Minerva Surgical, Inc | 1 | $15 |
| Medicem Inc. | 1 | $13 |
How this compares
$2,135 in reported general payments places this provider in the 65th percentile of 763 obstetrics & gynecology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 29 | $1,449 |
| ProgesteroneProgesterone, Micronized | 11 | $438 |
| Clobetasol Propionate | 14 | $356 |
| Medroxyprogesterone Acetate | 14 | $52 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Hendersonville
- William NasonHendersonville$8K
- Helen CavasinHendersonville$8K
- Grover MayJohnson City$916K
- John GreenElizabethton$878K
- Brent LaingElizabethton$480K
- Larry FieldsKnoxville$323K
- Michael SwanNashville$146K
- Clarinda Burton-ShannonLebanon$114K
- Royce AdkinsNashville$95K
- Olga MuldoonNashville$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.